Professionals Services Insights Community
About Offices Careers
Home / Insights / "Patents, Exclusivity, ...

June 11, 2007

"Patents, Exclusivity, and Generic Drugs" at the Food and Drug Law Institute

This event has already occurred.

Related Services

Industries

Related Insights

AI and Enablement After Amgen v. Sanofi: Implications for Life Sciences Patents
AI and Enablement After Amgen v. Sanofi: Implications for Life Sciences Patents

October 01, 2025

5min
FDA Announces Autism-Related Initiatives, Malaria Guidance, CBER Leadership, Pediatric Voucher Bill, and LDT Rule Rescinded
FDA Announces Autism-Related Initiatives, Malaria Guidance, CBER Leadership, Pediatric Voucher Bill, and LDT Rule Rescinded

September 29, 2025

5min
The Official Release of the Spring 2025 Unified Agenda, the Make America Healthy Again Commission Releases Strategy Report, CDER & CBER New Rare Disease Evidence Principles (RDEP), and Launch of Green List for GLP-1 Ingredients
The Official Release of the Spring 2025 Unified Agenda, the Make America Healthy Again Commission Releases Strategy Report, CDER & CBER New Rare Disease Evidence Principles (RDEP), and Launch of Green List for GLP-1 Ingredients

September 16, 2025

5min
View More

Events

Alicia Russo to Speak at PLI on Navigating the Evolving CRISPR IP Landscape
Alicia Russo to Speak at PLI on Navigating the Evolving CRISPR IP Landscape

November 21, 2025 New York, NY - PLI

Register for the Event
David Barr to Speak at PLI on Pharmaceutical & BiotechPatent Law
David Barr to Speak at PLI on Pharmaceutical & BiotechPatent Law

November 21, 2025 New York, NY - PLI

Register for the Event